HOB Biotech Group Corp Ltd
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, Ch… Read more
Market Cap & Net Worth: HOB Biotech Group Corp Ltd (688656)
HOB Biotech Group Corp Ltd (SHG:688656) has a market capitalization of $1.19 Billion (CN¥8.76 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #8940 globally and #1768 in its home market, demonstrating a 0.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HOB Biotech Group Corp Ltd's stock price CN¥138.04 by its total outstanding shares 63479740 (63.48 Million).
HOB Biotech Group Corp Ltd Market Cap History: 2021 to 2026
HOB Biotech Group Corp Ltd's market capitalization history from 2021 to 2026. Data shows growth from $524.15 Million to $1.19 Billion (17.01% CAGR).
HOB Biotech Group Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HOB Biotech Group Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.05x
HOB Biotech Group Corp Ltd's market cap is 2.05 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
22.45x
HOB Biotech Group Corp Ltd's market cap is 22.45 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $524.15 Million | $317.71 Million | $86.19 Million | 1.65x | 6.08x |
| 2022 | $282.60 Million | $320.39 Million | $41.65 Million | 0.88x | 6.78x |
| 2023 | $295.54 Million | $394.41 Million | $47.33 Million | 0.75x | 6.24x |
| 2024 | $826.24 Million | $402.34 Million | $36.80 Million | 2.05x | 22.45x |
Competitor Companies of 688656 by Market Capitalization
Companies near HOB Biotech Group Corp Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to HOB Biotech Group Corp Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
HOB Biotech Group Corp Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, HOB Biotech Group Corp Ltd's market cap moved from $524.15 Million to $ 1.19 Billion, with a yearly change of 17.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.19 Billion | -10.25% |
| 2025 | CN¥1.33 Billion | +61.05% |
| 2024 | CN¥826.24 Million | +179.57% |
| 2023 | CN¥295.54 Million | +4.58% |
| 2022 | CN¥282.60 Million | -46.08% |
| 2021 | CN¥524.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of HOB Biotech Group Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.19 Billion USD |
| MoneyControl | $1.19 Billion USD |
| MarketWatch | $1.19 Billion USD |
| marketcap.company | $1.19 Billion USD |
| Reuters | $1.19 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.